VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | CAR-T cell therapy DLBCL landscape

Ulrich Jäger, MD, of the Medical University of Vienna, Vienna, Austria, discusses the current state of the art and future directions of CAR-T cell therapy in diffuse large B-cell lymphoma (DLBCL) and novel data presented at EHA 2020. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter